» Articles » PMID: 7718512

Defective IL-5-receptor-mediated Signaling in B Cells of X-linked Immunodeficient Mice

Overview
Journal Int Immunol
Date 1995 Jan 1
PMID 7718512
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Murine (m) IL-5 induces proliferation and differentiation of both Ly-1+ B cells and activated conventional B cells. X-linked immunodeficient (XID) mice do not respond to thymus-independent type II antigens, and have an abnormal response to a variety of activation signals through Ig receptors, CD40 and cytokine receptors. Furthermore, XID mice show a B cell specific defect, reflected in decreased numbers of IL-5R alpha+ B cells and reduced responsiveness of IL-5R alpha+ B cells to mIL-5. We generated IL-5R alpha transgenic (5R alpha-Tg) mice in which B cells expressed recombinant IL-5R alpha. We crossed male 5R alpha-Tg mice with female XID mice and used their offspring to determine the IL-5 responsiveness of these B cells. All B cells of F1 male mice carrying the xid gene together with the transgene expressed the recombinant IL-5R alpha. However, those mice lacked Ly-1 B cells and their B cells acquired responsiveness to mIL-5. Interestingly, XID-5R alpha-Tg B cells, but not XID B cells, acquired mIL-5 proliferative and Ig-secretory responsiveness only in the presence of suboptimal doses of lipopolysaccharide. Stimulation of these B cells with mIL-5 plus phorbol myristate acetate induced proliferation, but not Ig secretion. These results indicate that the impaired mIL-5 responsiveness of B cells in XID mice is due to an abnormality of IL-5R-mediated signaling which may correlate with the xid gene mutation, alteration of a single amino acid of Bruton's tyrosine kinase.

Citing Articles

Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24.

Ying Z, Hardikar S, Plummer J, Hamidi T, Liu B, Chen Y Cell Mol Immunol. 2023; 20(12):1487-1498.

PMID: 37990035 PMC: 10687020. DOI: 10.1038/s41423-023-01106-w.


Upregulated Fcrl5 disrupts B cell anergy and causes autoimmune disease.

Ono C, Tanaka S, Myouzen K, Iwasaki T, Ueda M, Oda Y Front Immunol. 2023; 14:1276014.

PMID: 37841260 PMC: 10569490. DOI: 10.3389/fimmu.2023.1276014.


Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.

Neys S, Hendriks R, Corneth O Front Cell Dev Biol. 2021; 9:668131.

PMID: 34150760 PMC: 8213343. DOI: 10.3389/fcell.2021.668131.


Btk regulates multiple stages in the development and survival of B-1 cells.

Contreras C, Halcomb K, Randle L, Hinman R, Gutierrez T, Clarke S Mol Immunol. 2007; 44(10):2719-28.

PMID: 17207856 PMC: 2567238. DOI: 10.1016/j.molimm.2006.11.023.


Functional dissection of the cytoplasmic subregions of the interleukin-5 receptor alpha chain in growth and immunoglobulin G1 switch recombination of B cells.

Moon B, Yoshida T, Shiiba M, Nakao K, Katsuki M, Takaki S Immunology. 2001; 102(3):289-300.

PMID: 11298827 PMC: 1783180. DOI: 10.1046/j.1365-2567.2001.01196.x.